Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€104.20

€104.20

1.850%
1.9
1.850%
€110.00
 
23.02.24 / Tradegate WKN: A0LD6E / Name: Gerresheimer / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Gerresheimer AG Stock

There is an upward development for Gerresheimer AG compared to yesterday, with an increase of €1.90 (1.850%).
Currently there is a rather positive sentiment for Gerresheimer AG with 5 Buy predictions and 0 Sell predictions.
With a target price of 110 € there is a slightly positive potential of 5.57% for Gerresheimer AG compared to the current price of 104.2 €.
So far the community has only identified positive things for Gerresheimer AG stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Gerresheimer is a German-based company that specializes in the production of high-quality glass and plastic packaging solutions for the healthcare industry. The company's products are used to store and transport medicines, vaccinations, and other healthcare products. With a global footprint, Gerresheimer operates in Europe, North America, South America, and Asia, serving leading pharmaceutical and life science companies. The company is publicly traded on the Frankfurt Stock Exchange and has a strong reputation for innovation, quality, and sustainability.

Pros and Cons of Gerresheimer AG in the next few years

Pros
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Gerresheimer AG vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Gerresheimer AG 1.850% 15.971% 9.858% 31.815% 10.032% 21.445% 50.905%
Neogen Corp. -0.630% -2.484% 3.289% -13.260% -14.208% -52.424% -41.787%
Bio-Rad Labs Inc. A 0.580% -1.139% 7.571% -31.940% 6.471% -36.204% -
Merit Medical Systems 0.680% -0.676% -0.676% 9.701% 8.088% 57.725% 40.027%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-11

In general, the financials of Gerresheimer, a company in the Healthcare Equipment & Supplies industry, appear to be relatively stable with a few areas of concern. A closer examination of their financial statements reveals both positive and negative aspects.

Revenue Growth: Over the years, Gerresheimer's total revenue has shown steady growth. Between 2020 and 2022, the total revenue increased from €1.42 billion to €1.82 billion. This continuous increase indicates that the company has been able to grow its business even during challenging times.

Improvement in Gross Profit: The company's gross profit has also improved over the years. Gerresheimer's gross profit increased from €437.6 million in 2020 to €546.8 million in 2022, signifying a more efficient operation and potentially higher profitability.

Comments

systinvest hat das Wertpapier Gerresheimer AG in seinem Wikifolio Aktienwertselektion mit System gekauft.
Show more

Sell Gerresheimer AG
Show more

Sell Gerresheimer AG
Show more

News

EQS-News: Gerresheimer decisively continues on profitable growth course in financial year 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
EQS-News: Gerresheimer decisively continues on profitable growth course in financial year 2023
EQS-News: Gerresheimer decisively continues on profitable growth course in financial year 2023
EQS-News: Gerresheimer AG: Gerresheimer and Aptar Digital Health collaborate to develop integrated solution for cancer therapy : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
EQS-News: Gerresheimer AG: Gerresheimer and Aptar Digital Health collaborate to develop integrated solution for cancer therapy 
EQS-News: Gerresheimer AG: Gerresheimer and Aptar Digital Health collaborate to develop integrated solution for cancer therapy 
EQS-News: Gerresheimer AG: Guido Pickert to head up Investor Relations at Gerresheimer: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
EQS-News: Gerresheimer AG: Guido Pickert to head up Investor Relations at Gerresheimer
EQS-News: Gerresheimer AG: Guido Pickert to head up Investor Relations at Gerresheimer